Your browser doesn't support javascript.
loading
Bullous vesicant-type reaction to docetaxel along the venous tract: A case report.
Su, Jane; Bernard, Laurence; Colantonio, Sophia; Norgaard, Alexander; Hirte, Hal W; Eiriksson, Lua.
Afiliação
  • Su J; DeGroote School of Medicine, Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada.
  • Bernard L; DeGroote School of Medicine, Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada.
  • Colantonio S; Division of Gynecologic Oncology, Juravinski Hospital & Cancer Centre, Department of Obstetrics and Gynecology, McMaster University, Hamilton, Ontario, Canada.
  • Norgaard A; Department of Dermatology, University of Ottawa, Ontario, Canada.
  • Hirte HW; Department of Obstetrics and Gynecology, McMaster University, Hamilton, Ontario, Canada.
  • Eiriksson L; Division of Medical Oncology, Juravinski Hospital & Cancer Centre, Department of Oncology, McMaster University, Hamilton, Ontario, Canada.
Gynecol Oncol Rep ; 34: 100640, 2020 Nov.
Article em En | MEDLINE | ID: mdl-33005719
ABSTRACT
Docetaxel is an anti-neoplastic agent commonly used to treat major solid tumors. Common toxicities of docetaxel include neutropenia, alopecia, nausea and vomiting. While docetaxel is typically considered an irritant, we present the case report of a 54-year-old female with high-grade undifferentiated uterine sarcoma who experienced a standard infusion reaction during a docetaxel infusion, followed by an atypical, delayed vesicant-type reaction, without a clear extravasation history.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2020 Tipo de documento: Article